PLX
Protalix Biotherapeutics Inc
AMEX: PLX · HEALTHCARE · BIOTECHNOLOGY
$1.91
-1.00% today
Updated 2026-06-05
Market cap
$165.98M
P/E ratio
10.84
P/S ratio
2.17x
EPS (TTM)
$0.19
Dividend yield
—
52W range
$1 – $3
Volume
0.8M
Protalix Biotherapeutics Inc (PLX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$1.91
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 10.84x (capped 25x) · Margin: 20.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.